Concepedia

T. Hasegawa

TH

Statistics

Publications

4

Citations

86

H-Index

4

Active since

1981

Affiliations

Zeria Pharmaceutical (Japan)(Current)

T. Hasegawa is an author at Zeria Pharmaceutical (Japan) specializing in medicine, enzyme inhibition, and carbonic anhydrase inhibitors.

Publications per year

1981–1997

4

Publications

4

Dysplasia during pregnancy: a cytologic follow-up study.

Kayo Kiguchi, Marluce Bibbo, T. Hasegawa et al. · PubMed · 1981 · 29 citations

, , +15

Binding of dorzolamide and its metabolite, N-deethylated dorzolamide, to human erythrocytes in vitro.

T. Hasegawa, Kaori Hara, Shunsuke HATA · Drug Metabolism and Disposition · 1994 · 23 citations

, , +11

Functions of purified gB, gE:gI, and gH:gL, and their sialyl residues in varicella-zoster virus infection

Kimíyasu Shiraki, Hitoshi Sato, Jun Yamamura et al. · Archives of Virology · 1997 · 18 citations

, , +11

In vitro metabolism of dorzolamide, a novel potent carbonic anhydrase inhibitor, in rat liver microsomes.

T. Hasegawa, Ken‐ichi Hara, Toshie KENMOCHI et al. · Drug Metabolism and Disposition · 1994 · 16 citations

, , +15

1–4 of 4